upvote
A valuable application not mentioned here is streamlining synthesis and manufacturing to lower the costs of current drugs. That would positively impact millions more people than a new treatment for advanced pancreatic cancer. But there's not as much potential profit so....
reply
Manufacturing costs of most drugs are miniscule. Virtually all of their costs and from R&D and the regulatory process.
reply
How exactly is there no potential for large profit there? I’d say there potential for huge profit if you reduce cost of manufacturing drugs!
reply
The cost of manufacturing drugs is not where pharma makes it’s profits. Look at the margins for competitive generic drugs and over the counter medicine. Margins are tight.

Pharma makes bank on drugs that are patent protected. Squeezing the manufacturing cost is a small gain on top of that.

reply
Yip, drugs are similar to software in this regard. Expensive to develop, very cheap to replicate. It'd make vastly more sense as a nationalized industry, because I think a profit motive is not only unnecessary, but actively harmful because the drugs that help society the most, and the drugs that make the most money, have little overlap.

If a big pharma had the choice between an expensive treatment that could help treat any cancer, or an extremely cheap treatment that could prevent any cancer - which would they pick? The answer when you're motivated by profit is unfortunately different than the one when you're motivated by social benefit. And this is more than just a thought experiment because this issue is going to drive which type of treatments are pursued.

reply
Problem with those expensive treatments is that there are not that many cases. So profit from each is big but overall they add up to less. Getting everyone who can afford it on planet on some relatively cheap drug would be lot more profitable overall.

Get million out of thousand people or ten out of billion people... Later would be preferable.

reply
Well there's also the third option of get a million out of a billion people. And that's only one side of the perverse equation. The other is rent-seeking. A treatment that needs to be redone or repeatedly boosted is far more profitable than a treatment that simply solves something once and for all, especially if that 'solving' treatment can be done cheaply.
reply
After medicine, construction, flight, government, education and food production
reply
What does flight have to do with anything else in that list? And what about it? Make it cheaper? Greener? Just odd to put such a specific mode of transportation in an otherwise broad list.
reply
Mostly that planes already have good autopilot but still most crashes are due to human error. There is also a reasonably high barrier to entry to piloting. One that can majorly be removed by current autopilot + purpose built AI and anyone should be able to fly without much overhead.
reply
> There is also a reasonably high barrier to entry to piloting. One that can majorly be removed by current autopilot + purpose built AI and anyone should be able to fly without much overhead.

Being a doctor in America has a high barrier to entry.

It’s not because medical science is difficult.

It’s because the American Medical Association (aka, doctor’s union) limits the number of new doctors and medical students each year.

If you 2x the number of medical students, resulting in 1.5x number of qualified doctors, resulting in perhaps 20-30% lower salaries, and maybe 5-10% lower cost to patients.

But no, preserving a doctor’s middle-class salary is more important than lowering patients’ costs.

reply
Ah yes the doctor’s union which has a ~15% membership rate to said union. What a powerful union, when is the last time they had a strike?

Google “number medical students over time”

Then google “number residency slots over time”

Then notice how both of them have been increasing significantly over time.

Then compare the income percentile for doctors in US vs say Canada, Australia etc. all are top 1-3%. Doctors are paid well relative to median salary in every first world country.

Then google “physician percent healthcare costs” and learn that physician pay is about 8-10% of total healthcare spending. Then realize about 40% of that $ immediately goes back to the government via various taxes, so even if you paid physicians nothing you’d only save about 5% of healthcare spending.

Do you not try to verify any information you read before confidently regurgitating it at a later point? You really should…

reply
And yet they go for the arts first...
reply
> Drug discovery is extremely regulated process

I actually don’t think this is a strong argument.

AI does very well following rules.

Proving your drug works is hard, but an LLM can help you come up with the ideas.

reply
>AI does very well following rules.

How many of these "we sandboxed it and said not to do Y, but then it went and did it!" stories would you consider necessary to disprove that?

It may be good at following rules 99.99% of the time but if someone launches a million times more parallel agents than they would hire humans, it might still be much worse in practice...

"We've been told we must find an effective drug candidate here, and to follow this process for evaluating the quality of the candidate, but actually we could subtly change the analysis like this to make this candidate look favorable enough..."

(And then compare that to deterministic algorithms...)

reply
We are not perfect as human beings, and we can’t expect AI, which is modeled after us to be perfect too. This fear of AI is irrational.

The argument here is that AI can run permutations faster than any human can. And, feeding it a company’s proprietary data about what worked, what did not, how it worked and so on can be invaluable at accelerating the discovery process of new drugs.

Plus, it can work 24/7/365.

reply
We totally can expect software to be perfect. And I never ever accidentally hacked anyone.

People who behave like OpenAI and Antropic AI does when controlled by those companies get punished instead of celebrated.

reply
the thing is we are not short on "ideas" in the drug development process
reply
Maybe AI would be better put to use helping us determine which ideas are good then
reply
We have clinical trials for that. I’d also suggest that the first step in offering fixes for a complex problem should be educating yourself about the nature of that problem.
reply
Extremely expensive and time consuming clinical trials. If we’d increase success rate by even few % by selecting better candidates it would be huge.
reply
There’s no indication of ML systems expediting the clinical trial process, only the “brainstorming” part.
reply
Because human trials are so expensive that will be all the more reason to pre-screen with AI, like we already do with traditional simulations and things like proteome-wide off-target profiling.

There's no regulation on not doing a trial because your oracle machine told you it was an expensive dead end.

reply